Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
H2020Обмен на изследователи2020–2025

IPN-Bio · Integrated Photonic-Nano Technologies for Bioapplications

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2020-03-01 → 2025-08-31
Финансиране от ЕС
818 800 €
Участници
14
Схема
MSCA-RISE

Линиите свързват координатора с партньорите.

Накратко на български

Фотонни технологии, наноматериали и 2D структури се разработват за по-бърза диагностика на заболявания, както и за контрол на храните и околната среда. Тези инструменти помагат за по-точно откриване на болести, което подобрява здравето и качеството на живот на хората.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Integrated Photonic-Nano Technologies for Bioapplications

One of the major challenges of the 21st century is related to human health, medical diagnosis, food and environmental safety. One in eight people worldwide will be aged 65 or older by 2030, which works out to one billion people across the globe. Recent statistics revealed that approximately 80% of older adults have at least one chronic disease and 68% have at least two. Several chronic diseases cause almost two-thirds of all deaths each year. For example, cancer is responsible for an estimated 9.6 million deaths in 2018 reported by the WHO. The IPN-Bio aims to foster and develop long-term interdisciplinary, inter-sectoral and international collaboration between participating organisations through R&I staff exchanges to share knowledge and ideas, transfer skills and boost career opportunities. The project objectives and challenges present a balanced mix between industrial application focused knowledge transfer and development and more far-looking studies for potentially ground-breaking applications by exploiting new emerging opportunities with the integration of photonic technologies, nanotech and advanced 2D materials for the applications in health care, biomedical early diagnosis, food safety and environmental monitoring. Through the development of bio-nano-photonics technologies, IPN-Bio will enable faster and more accurate diagnosis for a range of diseases, leading to a real gain in human health and better overall quality of life.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

IPN-Bio (Integrated Photonic-Nano Technologies for Bio-applications) aims to foster and develop long-term international, interdisciplinary and inter-sectoral collaboration between Europe, USA, Latin America and China. IPN-Bio consortium consists of 13 world-leading organisations from eight countries (4 EU universities, 3 EU companies, 6 TC Partner organisations) working at the frontier of the field with the complementary expertise in the multidiscipline of Photonics, Nanotechnology and Biotechnology. IPN-Bio will implement strategies of excellence science through a total of 218 person-month of structured international and inter-sectoral staff exchanges involving 36 individual researchers. The R&I staff exchanges and network activities will provide an excellent platform for the exchanged researchers to share the knowledge and ideas, transfer the skills and boost career opportunities. The project’s objectives and challenges present a balanced mix between industrial application focused knowledge transfer and development and more far-looking studies for potentially ground-breaking applications by exploiting new emerging opportunities with the integration of photonics technology and advanced nanomaterials for the applications in health care, biomedical diagnosis, food safety and environmental monitoring. The IPN-Bio network will forge strong collaborative relationships between participating organisations, push Europe at the forefront of global biophotonics research community, and strengthen Europe’s human capital, competitiveness and economy growth.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз